ArriVent BioPharma (AVBP) Prepaid Assets (2023 - 2026)

ArriVent BioPharma (AVBP) has 4 years of Prepaid Assets data on file, last reported at $20.8 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 2159.0% year-over-year to $20.8 million; the trailing twelve-month figure through Mar 2026 stood at $20.8 million (up 2159.0% YoY), and the FY2025 full-year result was $60000.0, down 99.26% from the prior year.
• Prepaid Assets climbed to $20.8 million in Q1 2026, from $60000.0 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $20.8 million in Q1 2026 to a low of $60000.0 in Q4 2025.
• A 4-year average of $6.9 million and a median of $7.8 million in 2024 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets soared 6240.62% in 2024 and tumbled 99.26% in 2025, its largest moves.
• Tracing AVBP's Prepaid Assets over 4 years: stood at $128000.0 in 2023, then soared by 6240.62% to $8.1 million in 2024, then plunged by 99.26% to $60000.0 in 2025, then jumped by 34613.33% to $20.8 million in 2026.
• Business Quant data shows AVBP's Prepaid Assets at $20.8 million in Q1 2026, $60000.0 in Q4 2025, and $450000.0 in Q3 2025.